Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Summary: Roku (ROKU) - Roku currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] - Over the past week, Roku shares increased by 0.82%, while the Zacks Broadcast Radio and Television industry declined by 0.13% [5] - In the last quarter, Roku shares rose by 50.73%, and over the past year, they increased by 37.93%, significantly outperforming the S&P 500, which rose by 16.04% and 12.11% respectively [6] - Roku's average 20-day trading volume is 2,616,092 shares, indicating a bullish sign as the stock is rising with above-average volume [7] Earnings Outlook - In the past two months, one earnings estimate for Roku has increased, while none have decreased, leading to a consensus estimate improvement from -$0.19 to -$0.18 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions, indicating positive sentiment [9] Conclusion - Considering the positive momentum indicators and earnings outlook, Roku is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [10][11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Caterpillar (CAT) - Caterpillar currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance [2][3] - The stock has shown a price increase of 2.03% over the past week, outperforming the Zacks Manufacturing - Construction and Mining industry, which rose by 0.66% [5] - Over the last month, CAT's shares increased by 13.13%, significantly higher than the industry's 4.7% performance [5] - In the past quarter, CAT shares rose by 38.97%, while the S&P 500 only increased by 16.04% [6] - Year-to-date, CAT's shares are up 12.22%, compared to the S&P 500's 12.11% [6] Trading Volume - The average 20-day trading volume for CAT is 2,584,124 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, 2 earnings estimates for CAT have been revised upwards, while 1 estimate was revised downwards, leading to an increase in the consensus estimate from $18.73 to $18.80 [9] - For the next fiscal year, 4 estimates have moved upwards with no downward revisions, indicating positive sentiment [9] Conclusion - Given the positive momentum indicators and earnings outlook, CAT is positioned as a strong buy candidate for investors seeking short-term gains [11]

Company Overview - LENZ Therapeutics, Inc. currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook for investors [4] Performance Metrics - Over the past week, LENZ shares have increased by 6.64%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.16% [6] - In a longer time frame, LENZ's monthly price change is 13.09%, compared to the industry's 3.31% [6] - Over the past quarter, LENZ shares have surged by 26.99%, and over the last year, they have gained 49.13%, while the S&P 500 has only increased by 16.04% and 12.11%, respectively [7] Trading Volume - The average 20-day trading volume for LENZ is 330,002 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for LENZ has been revised upward, while none have been revised downward, leading to an increase in the consensus estimate from -$2.85 to -$2.81 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the strong performance metrics and positive earnings outlook, LENZ Therapeutics, Inc. is positioned as a promising investment opportunity with a Momentum Score of A [12]

Company Overview - ProKidney Corp. (PROK) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to the market [4] Price Performance - Over the past week, PROK shares have surged by 612.49%, significantly outperforming the Zacks Medical - Drugs industry, which increased by 1.75% [6] - In a longer timeframe, PROK's monthly price change is 292.82%, compared to the industry's 1.25% [6] - Over the past quarter, shares of PROK have increased by 349.87%, and they have gained 39.83% in the last year, while the S&P 500 has only moved 16.04% and 12.11%, respectively [7] Trading Volume - The average 20-day trading volume for PROK is 36,681,320 shares, which is a useful indicator of market interest and momentum [8] Earnings Outlook - In the past two months, one earnings estimate for PROK has moved higher, while none have moved lower, resulting in an increase in the consensus estimate from -$0.52 to -$0.49 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Considering the strong price performance, trading volume, and positive earnings outlook, PROK is positioned as a promising momentum pick with a Momentum Score of A and a Zacks Rank of 2 (Buy) [12]

Company Overview - Zevra Therapeutics (ZVRA) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook for investors [3] Price Performance - ZVRA shares have increased by 28.64% over the past week, significantly outperforming the Zacks Medical - Drugs industry, which rose by 1.75% during the same period [5] - Over the past month, ZVRA's price change is 45.18%, compared to the industry's 1.25% [5] - In the last quarter, ZVRA shares have risen by 74.97%, and over the past year, they have gained 95.57%, while the S&P 500 has only moved 16.04% and 12.11%, respectively [6] Trading Volume - ZVRA's average 20-day trading volume is 1,122,698 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Estimates - In the past two months, three earnings estimates for ZVRA have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $0.31 to $1.35 [9] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions during the same period [9] Conclusion - Given the strong momentum indicators and positive earnings outlook, ZVRA is positioned as a solid momentum pick for investors [11]

Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the aim of buying high and selling even higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps define momentum characteristics, with Woodward (WWD) currently holding a Momentum Style Score of A [2] Group 2: Woodward's Performance Metrics - Woodward has a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance in the market [3] - Over the past week, WWD shares increased by 2.59%, while the Zacks Aerospace - Defense Equipment industry rose by only 0.09% [5] - In the last quarter, WWD shares surged by 44.91%, and over the past year, they are up 38.44%, significantly outperforming the S&P 500, which increased by 17.01% and 13.4% respectively [6] Group 3: Trading Volume and Earnings Outlook - WWD's average 20-day trading volume is 508,964 shares, which is a bullish indicator when combined with rising stock prices [7] - In the past two months, three earnings estimates for WWD have been revised upwards, increasing the consensus estimate from $6.21 to $6.28 [9] - The positive trend in earnings estimate revisions suggests a promising outlook for WWD [8]

Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the strategy of "buying high, hoping to sell even higher" [1] - The Zacks Momentum Style Score helps investors identify which metrics are effective for assessing momentum in stocks [2] Group 2: Watts Water (WTS) Analysis - Watts Water currently has a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - Over the past week, WTS shares increased by 3.8%, outperforming the Zacks Instruments - Control industry, which rose by 3.51% [6] - In the last quarter, WTS shares rose by 31.02%, and over the past year, they increased by 39%, compared to the S&P 500's gains of 19.67% and 12.87% respectively [7] Group 3: Trading Volume and Earnings Outlook - WTS has an average 20-day trading volume of 159,698 shares, indicating a bullish sign when combined with rising stock prices [8] - In the past two months, one earnings estimate for WTS increased, raising the consensus estimate from $9.28 to $9.42 [10] - The positive earnings outlook contributes to WTS's strong performance and momentum score [9][12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Oric Pharmaceuticals, Inc. (ORIC) - ORIC currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, ORIC shares increased by 4.75%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.88% [5] - In the last quarter, ORIC shares surged by 140.04%, and over the past year, they gained 19.27%, while the S&P 500 only increased by 19.67% and 12.87%, respectively [6] - The average 20-day trading volume for ORIC is 896,080 shares, indicating a bullish sentiment as the stock is rising with above-average volume [7] Earnings Outlook - In the past two months, three earnings estimates for ORIC have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from -$1.98 to -$1.74 [9] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions during the same period [9] Conclusion - Given the positive performance metrics and earnings outlook, ORIC is positioned as a promising investment opportunity with a Momentum Score of B and a Zacks Rank of 2 (Buy) [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: TSMC - TSMC currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance in the market [3][4]. - The stock has shown a price increase of 2.73% over the past week, matching the performance of the Zacks Semiconductor - Circuit Foundry industry [6]. - Over the last month, TSMC's shares have increased by 7.25%, consistent with the industry's performance [6]. - In the longer term, TSMC shares have risen by 44.83% over the past quarter and 23.49% over the last year, outperforming the S&P 500's gains of 25.34% and 13.06%, respectively [7]. Trading Volume - TSMC's average 20-day trading volume is 9,544,473 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - Recent earnings estimate revisions for TSMC have been positive, with two estimates moving higher for the full year, raising the consensus estimate from $9.19 to $9.44 over the past 60 days [10]. - For the next fiscal year, two estimates have also increased, with no downward revisions noted [10]. Conclusion - Given the positive momentum indicators and earnings outlook, TSMC is positioned as a strong buy candidate for investors seeking short-term opportunities [12].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Group 1: Company Overview - Carvana (CVNA) currently holds a Momentum Style Score of B, indicating a positive momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Group 2: Price Performance - Over the past week, CVNA shares increased by 9.11%, outperforming the Zacks Internet - Commerce industry, which rose by 1.42% [5] - In a longer timeframe, CVNA shares have risen by 74.53% over the past three months and 192.12% over the last year, significantly outperforming the S&P 500's gains of 23.56% and 13.28%, respectively [6] Group 3: Trading Volume - The average 20-day trading volume for CVNA is 3,378,263 shares, which serves as a bullish indicator when combined with rising stock prices [7] Group 4: Earnings Outlook - In the last two months, four earnings estimates for CVNA have been revised upwards, increasing the consensus estimate from $4.48 to $4.99 [9] - For the next fiscal year, five estimates have moved higher while one has been revised downwards, indicating a generally positive earnings outlook [9] Group 5: Conclusion - Given the positive momentum indicators and earnings outlook, CVNA is positioned as a promising stock for near-term investment [11]